How Long May It Take To Settle Invokana, Farxiga and Other Diabetes Drug Lawsuits?


Individuals who have suffered diabetic ketoacidosis, leg or foot amputations, kidney damage, heart attacks or other injuries caused by side effects of Invokana, Farxiga or similar diabetes drugs may be entitled to financial compensation as a result the drug makers’ failure to adequately warn patients and the medical community about the risks associated with these newer medications.

The lawyers at Saiontz & Kirk, P.A. represent individuals throughout the United States who are pursuing an injury lawsuit following use of a new generation of diabetes drugs, which include:

Injury Lawyers

Find Out If You May Be Eligible for an Invokana Settlement


  • Invokana
  • Invokamet
  • Farxiga
  • Xigduo XR
  • Jardiance
  • Glyxambi

Although it appears that the drug makers knew or should have known about the risk of serious and potentially life-threatening injuries associated with their medications, they decided to aggressively market these new diabetes treatments while withholding information about the potential risk of problems.

The first Invokana lawsuits were filed in mid-2015, and there are now hundreds of cases pending nationwide involving individuals hospitalized due to ketoacidosis, who required leg or foot amputation, or suffered kidney failure. However, the proceedings all remain in the very early stages, and it will likely be several years before the drug makers consider settling.

In December 2016, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established centralized pretrial proceedings in the federal court system, where the cases are being managed in a manner similar to an Invokana class action lawsuit.

Throughout 2017 and 2018, the parties are preparing a small group of representative “bellwether” cases for early trial dates, which are designed to help gauge how juries may respond to certain allegations that will be repeated throughout the litigation. While the outcomes of these early trial dates will not be binding on other claims, they may influence eventual negotiations to resolve claims.

There have been no reports of Invokana settlements or other resolutions in the litigation, but our injury attorneys feel strongly that Johnson & Johnson and other manufacturers of these drugs will be required to pay substantial compensation as a result of their decision to place the desire for profits before the safety of users when they withheld information about the risks associated with their medications.

To review a potential claim for yourself or a loved one, request a free consultation and claim evaluation.

Factors Considered in Settling Invokana Injury Lawsuits

As coordinated discovery continues in cases pending nationwide, a substantial amount of additional information will be learned by the parties, including data about what the drug makers knew or should have known before the medications were introduced. This will have a substantial impact on Invokana settlement negotiations that may ultimately occur with the drug makers.

In addition to gauging the relative strengths and weaknesses of the various claims being pursued, negotiations to settle Invokana, Farxiga and other SGLT2 diabetes drug lawsuits will ultimately be based on what a jury may award to a specific plaintiff if their case goes before a jury.

At trial, a jury will weigh several factors in determining the amount of any Invokana damages award, including:

  • The extent and duration of the Invokana injury, including the medical care or treatment required as a result of the injury.
  • The amount of any lost wages, medical expenses or other economic damages.
  • The effect that the injury from Invokana had on the overall physical and mental health or well-being of the plaintiff.
  • The pain and mental anguish suffered in the past and which will likely be suffered in the future.
  • Any long-term injuries that may affect the plaintiff’s future health or enjoyment of life.

Find Out If You May Qualify for a Invokana Settlement

The first Invokana trial dates are expected to begin near the end of 2018, and there is no indication that the drug maker will consider settling Invokana cases before then. However, as the first bellwether trials approach, the drug makers will face increasing pressure to negotiate good faith settlement offers, or face the prospect of hundreds of individual trials going before juries throughout the U.S.

The personal injury lawyers at Saiontz & Kirk, P.A. provide free consultations and case evaluations to help individuals determine whether they may be entitled to pursue an Invokana settlement, Invokamet settlement, Farxiga settlement, Xigduo XR settlement, Jardiance settlement or Glyxambi settlement.

After calling our office at 1-800-522-0102 or requesting a free case review on-line, the facts and circumstances surrounding your potential case will be reviewed and evaluated by our lawyers.

If it is determined that you may eventually be eligible for to settle an Invokana case in the future, it is your decision whether to hire our law firm. All lawsuits are handled by our Invokana attorneys under a contingency fee agreement, which means that there are never any fees or expenses paid unless we are successful obtaining a recovery.

Austin Kirk
Last Updated September 8th, 2017
No Comments

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.